# PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation

> **NCT00352703** · PHASE4 · COMPLETED · sponsor: **Swedish Orphan Biovitrum** · enrollment: 145 (actual)

## Conditions studied

- Non-Hodgkin's Lymphoma
- Multiple Myeloma

## Interventions

- **DRUG:** Kepivance (Palifermin)

## Key facts

- **NCT ID:** NCT00352703
- **Lead sponsor:** Swedish Orphan Biovitrum
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2007-04
- **Final completion:** 2007-05
- **Target enrollment:** 145 (ACTUAL)
- **Last updated:** 2014-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00352703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00352703, "PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT00352703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*